Tesamorelin 10mg Research Peptide
Tesamorelin 10mg is a synthetic analog of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid modification at the N-terminus. This Tesamorelin 10mg compound is the only GHRH analog that has received FDA approval for a specific clinical indication and is supplied as a lyophilized powder for in vitro research.
Tesamorelin Research Background
Tesamorelin has been studied in clinical and preclinical settings for its potent stimulation of endogenous growth hormone secretion. Its unique N-terminal modification provides enhanced stability compared to native GHRH. Research applications include studies of GH axis stimulation, visceral adipose tissue regulation, lipodystrophy mechanisms, and metabolic signaling pathways. Tesamorelin 10mg research has contributed significantly to understanding the relationship between GH secretion and body composition regulation.
Published studies include research on visceral fat reduction mechanisms (PubMed: 20484485), GH axis pharmacology (PubMed: 23539727), and metabolic effects (PubMed: 25202879).
Tesamorelin 10mg Specifications
- Purity: ≥99% (HPLC verified)
- Molecular Weight: 5135.90 g/mol
- CAS Number: 218949-48-5
- Molecular Formula: C221H366N72O67S
- Appearance: White lyophilized powder
- Storage: -20°C long-term, 2-8°C short-term, protect from light and moisture
Testing and Quality Assurance
Each Tesamorelin 10mg vial is HPLC verified for purity. Full lot traceability maintained across all batches.
Shipping and Handling
Tesamorelin 10mg ships as lyophilized powder via US domestic 2nd Day Air. Same-day processing before 2:00 PM CST. Free shipping on orders over $200.
Related Research Peptides
Researchers studying GHRH pathways may also explore Sermorelin 10mg, CJC-1295 No DAC 5mg, or Ipamorelin 10mg. View our full catalog.
This product is furnished strictly for laboratory research purposes only. It is not intended for human consumption, medical applications, veterinary use, or household use.
